Melatonin influences insulin secretion primarily via MT 1 receptors in rat insulinoma cells (INS-1) and mouse pancreatic islets

Journal of Pineal Research

Volumn 52, Issue 4, 2012, Pages 446-459

  Mühlbauer, Eckhard ^a   Albrecht, Elke ^b   Bazwinsky Wutschke, Ivonne ^b   Peschke, Elmar ^b  

^a Saxon Academy of Sciences   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

cAMP cascade; inhibitory G protein; insulin secretion; melatonin MT 1 receptor; MT 1 receptor knockdown; pancreatic cell

Indexed keywords

CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GLUCAGON; GLUCAGON LIKE PEPTIDE 1; ISOBUTYLMETHYLXANTHINE; MELATONIN; MELATONIN 1 RECEPTOR; MESSENGER RNA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CLONE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EX VIVO STUDY; GENE SILENCING; IMMUNOCYTOCHEMISTRY; INSULIN RELEASE; INSULINOMA; KNOCKOUT MOUSE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PANCREAS ISLET; PROTEIN PHOSPHORYLATION; RADIOIMMUNOASSAY; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SUPERNATANT; TUMOR CELL; WILD TYPE;

1-METHYL-3-ISOBUTYLXANTHINE; ANIMALS; CELL LINE, TUMOR; CYCLIC AMP; HISTOCYTOCHEMISTRY; INSULIN; INSULIN-SECRETING CELLS; INSULINOMA; MELATONIN; MICE; MICE, KNOCKOUT; RATS; RECEPTOR, MELATONIN, MT1; STATISTICS, NONPARAMETRIC;

EID: 84859724255     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2012.00959.x     Document Type: Article

References (59)

1. Vanecek J,. Cellular mechanisms of melatonin action. Physiol Rev 1998; 78: 687-721.
2. Reppert SM, Weaver DR, Ebisawa T,. Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses. Neuron 1994; 13: 1177-1185.
3. Reppert SM, Godson C, Mahle CD, et al., Molecular characterization of a second melatonin receptor expressed in human retina and brain: the Mel1b melatonin receptor. Proc Natl Acad Sci U S A 1995; 92: 8734-8738.
4. Von Gall C, Stehle JH, Weaver DR,. Mammalian melatonin receptors: molecular biology and signal transduction. Cell Tissue Res 2002; 309: 151-162.
5. Prokopenko I, Langenberg C, Florez JC, et al., Variants in MTNR1B influence fasting glucose levels. Nat Genet 2009; 41: 77-81.
6. Bouatia-Naji N, Bonnefond A, Cavalcanti-Proenca C, et al., A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk. Nat Genet 2009; 41: 89-94.
7. Lyssenko V, Nagorny YCL, Erdos MR, et al., Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion. Nat Genet 2009; 41: 82-88.
8. Li C, Shi Y, You L, et al., Melatonin receptor 1A gene polymorphism associated with polycystic ovary syndrome. Gynecol Obstet Invest 2011; 72: 130-134.
9. Kemp DM, Ubeda M, Habener JF,. Identification and functional characterization of melatonin Mel 1a receptors in pancreatic beta cells: potential role in incretin-mediated cell function by sensitization of cAMP signaling. Mol Cell Endocrinol 2002; 191: 157-166.
10. Peschke E, Muhlbauer E, Musshoff U, et al., Receptor (MT(1)) mediated influence of melatonin on cAMP concentration and insulin secretion of rat insulinoma cells INS-1. J Pineal Res 2002; 33: 63-71.
11. Muhlbauer E, Peschke E,. Evidence for the expression of both the MT1- and in addition, the MT2-melatonin receptor, in the rat pancreas, islet and beta-cell. J Pineal Res 2007; 42: 105-106.
12. Ramracheya RD, Muller DS, Squires PE, et al., Function and expression of melatonin receptors on human pancreatic islets. J Pineal Res 2008; 44: 273-279.
13. Peschke E, Stumpf I, Bazwinsky I, et al., Melatonin and type 2 diabetes-a possible link? J Pineal Res 2007; 42: 350-358.
14. Bahr I, Muhlbauer E, Schucht H, et al., Melatonin stimulates glucagon secretion in vitro and in vivo. J Pineal Res 2011; 50: 336-344.
15. Nagorny CL, Sathandoori R, Voss U, et al., Distribution of melatonin receptors in murine pancreatic islets. J Pineal Res 2011; 50: 412-417.
16. Peschke E, Peschke D,. Evidence for a circadian rhythm of insulin release from perifused rat pancreatic islets. Diabetologia 1998; 41: 1085-1092.
17. Boden G, Ruiz J, Urbain JL, et al., Evidence for a circadian rhythm of insulin secretion. Am J Physiol 1996; 271: 246-252.
18. Peschke E, Peschke D, Hammer T, et al., Influence of melatonin and serotonin on glucose-stimulated insulin release from perifused rat pancreatic islets in vitro. J Pineal Res 1997; 23: 156-163.
19. Picinato MC, Haber EP, Cipolla-Neto J, et al., Melatonin inhibits insulin secretion and decreases PKA levels without interfering with glucose metabolism in rat pancreatic islets. J Pineal Res 2002; 33: 156-160.
20. Bailey CJ, Atkins TW, Matty AJ,. Melatonin inhibition of insulin secretion in the rat and mouse. Horm Res 1974; 5: 21-28.
21. Peschke E, Schucht H, Muhlbauer E,. Long-term enteral administration of melatonin reduces plasma insulin and increases expression of pineal insulin receptors in both Wistar and type 2-diabetic Goto-Kakizaki rats. J Pineal Res 2010; 49: 373-381.
22. Frankel BJ, Strandberg MJ,. Insulin release from isolated mouse islets in vitro: no effect of physiological levels of melatonin or arginine vasotocin. J Pineal Res 1991; 11: 145-148.
23. Peschke E, Bach AG, Muhlbauer E,. Parallel signaling pathways of melatonin in the pancreatic beta-cell. J Pineal Res 2006; 40: 184-191.
24. Peschke E, Fauteck JD, Musshoff U, et al., Evidence for a melatonin receptor within pancreatic islets of neonate rats: functional, autoradiographic, and molecular investigations. J Pineal Res 2000; 28: 156-164.
25. Muhlbauer E, Albrecht E, Hofmann K, et al., Melatonin inhibits insulin secretion in rat insulinoma beta-cells (INS-1) heterologously expressing the human melatonin receptor isoform MT2. J Pineal Res 2011; 51: 361-372.
26. Stumpf I, Muhlbauer E, Peschke E,. Involvement of the cGMP pathway in mediating the insulin-inhibitory effect of melatonin in pancreatic beta-cells. J Pineal Res 2008; 45: 318-327.
27. Stumpf I, Bazwinsky I, Peschke E,. Modulation of the cGMP signaling pathway by melatonin in pancreatic beta-cells. J Pineal Res 2009; 46: 140-147.
28. Pfaffl MW,. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001; 29: 2003-2200.
29. Liu C, Weaver DR, Jin X, et al., Molecular dissection of two distinct actions of melatonin on the suprachiasmatic circadian clock. Neuron 1997; 19: 91-102.
30. Jin X, Von Gall C, Pieschl RL, et al., Targeted disruption of the mouse Mel(1b) melatonin receptor. Mol Cell Biol 2003; 23: 1054-1060.
31. Muhlbauer E, Gross E, Labucay K, et al., Loss of melatonin signalling and its impact on circadian rhythms in mouse organs regulating blood glucose. Eur J Pharmacol 2009; 606: 61-71.
32. Renstrom E, Eliasson L, Rorsman P,. Protein kinase A-dependent and -independent stimulation of exocytosis by cAMP in mouse pancreatic B-cells. J Physiol 1997; 502: 105-118.
33. Ozaki N, Shibasaki T, Kashima Y, et al., cAMP-GEFII is a direct target of cAMP in regulated exocytosis. Nat Cell Biol 2000; 2: 805-811.
34. Kang G, Chepurny OG, Malester B, et al., cAMP sensor Epac as a determinant of ATP-sensitive potassium channel activity in human pancreatic beta cells and rat INS-1 cells. J Physiol 2006; 573: 595-609.
35. Chepurny OG, Hussain MA, Holz GG,. Exendin-4 as a stimulator of rat insulin I gene promoter activity via bZIP/CRE interactions sensitive to serine/threonine protein kinase inhibitor Ro 31-8220. Endocrinology 2002; 143: 2303-2313.
36. Leroux L, Durel B, Autier V, et al., Ins1 gene up-regulated in a beta-cell line derived from Ins2 knockout mice. Int J Exp Diabesity Res 2003; 4: 7-12.
37. Deltour L, Ledouque P, Blume N, et al., Differential expression of the two nonallelic proinsulin genes in the developing mouse embryo. Proc Natl Acad Sci U S A 1993; 90: 527-531.
38. Dubocovich ML, Delagrange P, Krause DN, et al., International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors. Pharmacol Rev 2010; 62: 343-380.
39. Jelinek LJ, Lok S, Rosenberg GB, et al., Expression cloning and signaling properties of the rat glucagon receptor. Science 1993; 259: 1614-1616.
40. Gromada J, Holst JJ, Rorsman P,. Cellular regulation of islet hormone secretion by the incretin hormone glucagon-like peptide 1. Pflugers Arch 1998; 435: 583-594.
41. Morgan PJ, Davidson G, Lawson W, et al., Both pertussis toxin-sensitive and insensitive g-proteins link melatonin receptor to inhibition of adenylate cyclase in the ovine pars tuberalis. J Neuroendocrinol 1990; 2: 773-776.
42. Steffens F, Zhou XB, Sausbier U, et al., Melatonin receptor signaling in pregnant and nonpregnant rat uterine myocytes as probed by large conductance Ca2+-activated K+ channel activity. Mol Endocrinol 2003; 17: 2103-2115.
43. Renzi A, Glaser S, Demorrow S, et al., Melatonin inhibits cholangiocyte hyperplasia in cholestatic rats by interaction with MT1 but not MT2 melatonin receptors. Am J Physiol Gastrointest Liver Physiol 2011; 301: G634-G643.
44. Soares JM, Jim JR, Masana MI, Ersahin C, Dubocovich ML,. Functional melatonin receptors in rat ovaries at various stages of the estrous cycle. J Pharmacol Exp Ther 2003; 306: 694-702.
45. Mcnulty S, Ross AW, Barrett P, et al., Melatonin regulates the phosphorylation of CREB in ovine pars tuberalis. J Neuroendocrinol 1994; 6: 523-532.
46. Mayr B, Montminy M,. Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat Rev Mol Cell Biol 2001; 2: 599-609.
47. Miller CP, Lin JC, Habener JF,. Transcription of the rat glucagon gene by the cyclic AMP response element-binding protein CREB is modulated by adjacent CREB-associated proteins. Mol Cell Biol 1993; 13: 7080-7090.
48. Oetchen E, Diedrich T, Eggers A, et al., Distinct properties of the cAMP-responsive element of the rat insulin I gene. J Biol Chem 1994; 269: 27036-67044.
49. Jhala US, Canettieri G, Screaton RA, et al., cAMP promotes pancreatic beta-cell survival via CREB-mediated induction of IRS2. Genes Dev 2003; 17: 1575-1580.
50. Jansson D, Ng AC, Fu A, et al., Glucose controls CREB activity in islet cells via regulated phosphorylation of TORC2. Proc Natl Acad Sci U S A 2008; 105: 10161-10166.
51. Screaton RA, Conkright MD, Katoh Y, et al., The CREB coactivator TORC2 functions as a calcium- and cAMP-sensitive coincidence detector. Cell 2004; 119: 61-74.
52. Damiola F, Le MinhN, Preitner N, et al., Restricted feeding uncouples circadian oscillators in peripheral tissues from the central pacemaker in the suprachiasmatic nucleus. Genes Dev 2000; 14: 2950-2961.
53. Sheynzon P, Korf HW,. Targeted deletions of Mel1a and Mel1b melatonin receptors affect pCREB levels in lactotroph and pars intermedia cells of mice. Neurosci Lett 2006; 407: 48-52.
54. Mackenzie RS, Melan MA, Passey DK, et al., Dual coupling of MT(1) and MT(2) melatonin receptors to cyclic AMP and phosphoinositide signal transduction cascades and their regulation following melatonin exposure. Biochem Pharmacol 2002; 63: 587-595.
55. Rucha A, Verspohl EJ,. Heterologous desensitization of insulin secretion by GIP (glucose-dependent insulinotropic peptide) in INS-1 cells: the significance of Galphai2 and investigations on the mechanism involved. Cell Biochem Funct 2005; 23: 205-212.
56. Witt-Enderby PA, Masana MI, Dubocovich ML,. Physiological exposure to melatonin supersensitizes the cyclic adenosine 3prime;,5prime;-monophosphate- dependent signal transduction cascade in Chinese hamster ovary cells expressing the human mt1 melatonin receptor. Endocrinology 1998; 139: 3064-3071.
57. Barrett P, Schuster C, Mercer J, et al., Sensitization: a mechanism for melatonin action in the pars tuberalis. J Neuroendocrinol 2003; 15: 415-421.
58. Asfari M, Janjic D, Meda P, et al., Establishment of 2-mercaptoethanol- dependent differentiated insulin-secreting cell lines. Endocrinology 1992; 130: 167-178.
59. Skelin M, Rupnik M, Cencic A,. Pancreatic beta cell lines and their applications in diabetes mellitus research. Altex 2010; 27: 105-113.